| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.009 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |